Boehringer Ingelheim: all 2,305 studies
Page 7 of 24. Open to participants first (62), then studies with results posted, then the rest; newest registration first within each.
- Ascertainment of EMR-based Clinical Covariates Among Patients Receiving Oral and Non-insulin Injected Hypoglycemic TherapyCompletedNCT02140645Results posted
- Oral and Non-insulin Injected Hypoglycemic Therapy Utilization PatternsCompletedNCT02138097Results posted
- BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid ArthritisCompletedNCT02137226Phase 3Results posted
- Long-term Observation PMS for AfatinibCompletedNCT02131259Results posted
- LUX-Head & Neck 4: Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapyTerminatedNCT02131155Phase 3Results posted
- Bioequivalence Study of Telmisartan Between Telmisartan 80 mg/Amlodipine 5 mg/Hydrochlorothiazide 12.5 mg (T80/A5/H12.5 mg) Fixed-dose Combination (FDC) Tablet and T80/H12.5 mg Tab and A5 mg (Encap A2.5 mg Tab x2) Concomitant UseCompletedNCT02129192Phase 1Results posted
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 1026706 in Male and Female Healthy Subjects and Patients With Osteoarthritis of the KneeCompletedNCT02126826Phase 1Results posted
- BI 836845 in Estrogen Receptor Positive Metastatic Breast CancerCompletedNCT02123823Phase 1Results posted
- Bioequivalence Study of Telmisartan Between T80/A5/H12.5 mg FDC Tablet and T80/A5 mg Tab and H12.5 mg Tab Concomitant UseCompletedNCT02121535Phase 1Results posted
- A 4 Week Study With BI 144807 in Patients >= 50 Years With Wet Age Related Macular DegenerationCompletedNCT02121522Phase 2Results posted
- Bioequivalence of a FDC Tablet of Linagliptin/Metformin (2.5mg/750mg) Extended Release in Healthy SubjectsCompletedNCT02121509Phase 1Results posted
- Pharmacokinetic Single Dose Trial of Empagliflozin in Children and Adolescents With Type 2 Diabetes MellitusCompletedNCT02121483Phase 1Results posted
- Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Metformin Extended Release (XR) Compared With Single TabletsCompletedNCT02106923Phase 1Results posted
- Reversal of Dabigatran Anticoagulant Effect With IdarucizumabCompletedNCT02104947Phase 3Results posted
- Bioavailability of Empagliflozin/Metformin Fixed Dose Combinations (FDCs) in Healthy Chinese VolunteersCompletedNCT02102932Phase 1Results posted
- Bioequivalence of Two Transdermal Clonidine Administrations in Healthy VolunteersCompletedNCT02096744Phase 1Results posted
- Combined Bronchodilators in Chronic Obstructive Pulmonary Disease and the Risk of Adverse Cardio-pulmonary EventsCompletedNCT02096731Results posted
- Afatinib in Subjects With Kidney DysfunctionCompletedNCT02096718Phase 1Results posted
- To Assess Safety, Tolerability and Pharmacokinetics of BI 416970 in Healthy Male VolunteersCompletedNCT02093819Phase 1Results posted
- To Evaluate the Effect of Inhaled Medication Together With Exercise and Activity Training on Exercise Capacity and Daily Activities in Patients With Chronic Lung Disease With Obstruction of AirwaysCompletedNCT02085161Phase 3Results posted
- Effectiveness and Safety of Different Doses of BI 1026706 in Patients With Postoperative Dental PainCompletedNCT02084511Phase 1Results posted
- Bioequivalence of a FDC Tablet of Linagliptin/Metformin (5mg/1000mg) Extended Release in Healthy SubjectsCompletedNCT02084082Phase 1Results posted
- Bioequivalence of a FDC Tablet of Linagliptin/Metformin (2.5mg/1000mg) Extended Release in Healthy Subjects.CompletedNCT02084056Phase 1Results posted
- Sequential Expansion of Comparative Effectiveness of AnticoagulantsCompletedNCT02081807Results posted
- Safety, Tolerability, and Pharmacokinetics of Single Doses BI 425809CompletedNCT02068690Phase 1Results posted
- The Comparative Safety and Effectiveness of Warfarin and Dabigatran Prescribed in the Non-valvular Atrial Fibrillation Population With Humana Healthcare CoverageCompletedNCT02061748Results posted
- Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 691751 in Healthy Asian Male VolunteersCompletedNCT02057835Phase 1Results posted
- BI 655066 Dose Ranging in Psoriasis, Active Comparator UstekinumabCompletedNCT02054481Phase 2Results posted
- GIOTRIF in First Line Therapy of Advanced NSCLC With EGFR-mutationsCompletedNCT02047903Results posted
- Pharmacokinetics and Safety in Healthy VolunteersCompletedNCT02045979Phase 1Results posted
- Interaction of BI 691751 With ItraconazoleCompletedNCT02044393Phase 1Results posted
- Afatinib in Patients With Non Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR) MutationsCompletedNCT02044380Phase 3Results posted
- Relative Bioavailability of Dabigatran Capsules, Pellets and Oral Solution in Healthy VolunteersCompletedNCT02044367Phase 1Results posted
- The Safety and Effectiveness of Warfarin and Dabigatran Prescribed in the Non-Valvular Atrial Fibrillation Population With DoD Healthcare CoverageCompletedNCT02043808Results posted
- Effectiveness of Two Different Doses of BI 1026706 on the Overall Peak-to-Peak (PtP) N2/P2-component Amplitude of Laser (Somatosensory, Radiant-heat) Evoked Potentials (LEP) in UVB(Ultraviolet)-Irradiated Skin in Healthy Male VolunteersCompletedNCT02037165Phase 1Results posted
- Pharmacokinetics and Bioavailability Study of Lasolvan Hard Capsules and Effervescent Tablets in Healthy VolunteersCompletedNCT02036775Phase 1Results posted
- Study to Evaluate the Effect on Lung Function and ECG When a Combination of Tiotropium Plus Olodaterol is Administered to Patients With COPD Either From a Single Inhaler or Each Compound is Administered After Each Other From Two Different InhalersCompletedNCT02030535Phase 2Results posted
- Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BI 655075 (Idarucizumab) Administered Alone or With Dabigatran Etexilate in Japanese Healthy SubjectsCompletedNCT02028780Phase 1Results posted
- Bioequivalence Study in Healthy Volunteers for Empagliflozin/Metformin Fixed Dose Combination Compared to Separate TabletsCompletedNCT02028767Phase 1Results posted
- Management of Gastrointestinal and Urogenital (GI/GU) Bleedings in Atrial Fibrillation Patients Using PradaxaCompletedNCT02022020Results posted
- Trial of Afatinib (BIBW 2992) + Cetuximab in Advanced Solid TumoursCompletedNCT02020577Phase 1Results posted
- Investigation of Potential Drug-drug Interactions Between Faldaprevir and the Immunosuppressant Drugs Cyclosporine or TacrolimusCompletedNCT02016625Phase 1Results posted
- Multiple Rising Does Study (Subcutaneous Doses) of BI 655064 in Male and Female Patients With Chronic Primary Immune Thrombocytopenic Purpura (ITP).TerminatedNCT02009761Phase 1Results posted
- Tiotropium+Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 2)CompletedNCT02006732Phase 3Results posted
- Volasertib + Decitabine in Patients With Acute Myeloid Leukemia (AML)TerminatedNCT02003573Phase 1Results posted
- Effect of Food and Increased Gastric pH Value on Bioavailability of a Single Dose of BI 207127 in Healthy Caucasian and Japanese SubjectsTerminatedNCT01983566Phase 1Results posted
- Nintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT01979952Phase 3Results posted
- Add-on to Micamlo BP TrialCompletedNCT01975246Phase 3Results posted
- Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Metformin Compared With Single TabletsCompletedNCT01975220Phase 1Results posted
- Open Dose Escalating Trial to Determine the Maximum Tolerated Dose in Paediatric Patients With Advanced Cancers for Whom no Therapy is KnownCompletedNCT01971476Phase 1Results posted
- Treatment With Rhinospray Plus in Patients With Acute Rhinitis in the Everyday Curative Routine in HungaryCompletedNCT01971086Results posted
- Empagliflozin add-on to Insulin in Type 1 Diabetes Mellitus Over 28 DaysCompletedNCT01969747Phase 2Results posted
- Characterization of Lung Function Profile of Inhaled Tiotropium + Olodaterol Fixed Dose Combination Compared to Fluticasone Propionate + Salmeterol Fixed Dose Combination in COPD PatientsCompletedNCT01969721Phase 3Results posted
- Ventilator Adapters for Combivent RespimatTerminatedNCT01969539Phase 4Results posted
- Thorough QT Study to Evaluate the Effects of BI 207127 (Deleobuvir) Combined With Faldaprevir on Cardiac Safety Parameters in Healthy Subjects.CompletedNCT01965431Phase 1Results posted
- Tiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1)CompletedNCT01964352Phase 3Results posted
- Efficacy and Safety of Actilyse 2 mg/ 2 ml in Comparison to Saline Solution in Patients With Central Venous Access Device OcclusionCompletedNCT01958164Phase 3Results posted
- Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of Single Escalating Doses of BI 1034020 Administered Intravenously or Subcutaneously to Male Healthy VolunteersTerminatedNCT01958060Phase 1Results posted
- BI 113608 Administered as Tablets Twice Daily Over 4 Weeks in Patients With Chronic Obstructive Pulmonary Disease Associated With Chronic BronchitisCompletedNCT01958008Phase 1Results posted
- Pharmacokinetics, Safety and Tolerability of the Combination of BI 207127 and Faldaprevir in Renal Impaired PatientsTerminatedNCT01957657Phase 1Results posted
- Phase I Dose Escalation Trial of Volasertib in Combination With Azacitidine in Patients With MDS or CMMLTerminatedNCT01957644Phase 1Results posted
- Safety and Efficacy of BI 695500 in Patients With Moderately to Severely Active Rheumatoid ArthritisTerminatedNCT01955733Phase 3Results posted
- Safety, Tolerability, PK and PD of BI 655075 and Establishment of BI 655075 Dose(s) Effective to Reverse Prolongation of Blood Coagulation Time by DabigatranCompletedNCT01955720Phase 1Results posted
- Afatinib (BIBW 2992) in Advanced Non-Small Cell Lung Cancer Patients With EGFR MutationCompletedNCT01953913Phase 3Results posted
- Pharmacokinetics and Pharmacodynamics of BI 695500 vs. Rituximab as First Line-treatment in Patients With Low Tumor Burden Follicular LymphomaCompletedNCT01950273Phase 1Results posted
- Post Prandial Glucose (PPG) Study of Empagliflozin in Japanese Patients With Type 2 Diabetes MellitusCompletedNCT01947855Phase 3Results posted
- Two-way Crossover Study in Healthy Male and Female Subjects to Evaluate the Bioequivalence of Jentadueto®.CompletedNCT01947153Phase 1Results posted
- Iota-Carrageenan Nasal Spray in Common ColdCompletedNCT01944631Phase 4Results posted
- Ipratropium Bromide in Peri-Operative COPDCompletedNCT01943552Phase 4Results posted
- Effect of BI 207127 + Faldaprevir on Blood Levels of Oral Contraceptives Containing Ethinylestradiol and LevonorgestrelTerminatedNCT01941615Phase 1Results posted
- BI 860585 Dose Escalation Single Agent and in Combination With Exemestane or With Paclitaxel in Patients With Various Advanced and/or Metastatic Solid TumorsCompletedNCT01938846Phase 1Results posted
- Observational Study of Adherence to LABA / LAMA in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01937390Results posted
- Efficacy of Buscopan® in Comparison With 654-II (Anisodamine) in Acute Gastric or Intestinal PainCompletedNCT01929044Phase 3Results posted
- Efficacy and Safety of Ibuprofen and Caffeine in Dental PainCompletedNCT01929031Phase 3Results posted
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Doses of BI 10773 TabletsCompletedNCT01924767Phase 1Results posted
- Safety, Tolerability and Pharmacokinetics of BI 113608 in Healthy Asian and Caucasian Male VolunteersCompletedNCT01922349Phase 1Results posted
- Single Rising Doses of BI 655064 in Healthy Chinese and Japanese Male VolunteersCompletedNCT01917916Phase 1Results posted
- Compare Efficacy and Safety of Telmisartan/Hydrochlorothiazide With Telmisartan/Hydrochlorothiazide Plus AmlodipineCompletedNCT01911780Phase 3Results posted
- Open Label Single Dose Phase I Trial of BI 201335 to Study Pharmacokinetics and Safety in Patients With Compensated Liver CirrhosisCompletedNCT01909778Phase 1Results posted
- Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BI 10773 in Type II Diabetes Patients With Different Degrees of Renal ImpairmentCompletedNCT01907113Phase 1Results posted
- Nintedanib (BIBF 1120) in MesotheliomaTerminatedNCT01907100Phase 2/3Results posted
- PMS of Trazenta on the Long-term Use as Add-on TherapyCompletedNCT01904383Results posted
- A Regulatory Requirement Non Interventional Study to Monitor Safety and Effectiveness of Trajenta Duo in Type 2 Diabetes Patients in KoreaCompletedNCT01903356Results posted
- Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)CompletedNCT01897532Phase 4Results posted
- Pradaxa Study in Non-valvular Atrial Fibrillation Patients With Severely Impaired Renal FunctionCompletedNCT01896297Phase 4Results posted
- Open Label Study Comparing Efficacy and Safety of Dabigatran Etexilate to Standard of Care in Paediatric Patients With Venous Thromboembolism (VTE)CompletedNCT01895777Phase 3Results posted
- Safety and Tolerability of BI 409306 in Patients With SchizophreniaCompletedNCT01892384Phase 1Results posted
- Relative Bioavailability of Ibuprofen From a Single Fixed Dose Combination Tablet of Ibuprofen and Caffeine Compared to Single Tablets of Ibuprofen and Ibuprofen LysinateCompletedNCT01879371Phase 1Results posted
- Effect of Empagliflozin Kinetics on Renal Glucose Reabsorption in Patients With Type II Diabetes and Healthy ControlsCompletedNCT01867307Phase 2Results posted
- LUX-Head&Neck 3: Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer After Platinum Based ChemotherapyCompletedNCT01856478Phase 3Results posted
- Impact of Ramadan on Achieving Joint National Committee (JNC) 7 Treatment Goals in CV Risk PatientsCompletedNCT01853839Results posted
- An Open Label Trial of Afatinib (Giotrif) in Treatment-naive (1st Line) or Chemotherapy Pre-treated Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Harboring EGFR Mutation(s)CompletedNCT01853826Phase 3Results posted
- Anticoagulant Utilization PatternCompletedNCT01847560Results posted
- Comparative Effectiveness of Oral AnticoagulantsCompletedNCT01847547Results posted
- Relative Bioavailability of 2 Fixed Dose Combinations of Linagliptin/Metformin Compared With Single TabletsCompletedNCT01845077Phase 1Results posted
- Bioequivalence of Empagliflozin and Metformin Given as a Fixed Dose Combination Compared to Single TabletsCompletedNCT01844531Phase 1Results posted
- Safety of Single Rising Doses and Relative Bioavailability of BI 691751CompletedNCT01843972Phase 1Results posted
- Safety, Tolerability and Pharmacokinetics of BI 409306 Tablets in Healthy Asian Male VolunteersCompletedNCT01841112Phase 1Results posted
- Safety, Tolerability and Pharmacokinetics of Multiple Rising Oral Doses of BI 1015550 Powder for Oral SolutionCompletedNCT01835899Phase 1Results posted
- BI 207127 / Faldaprevir Combination Therapy in Hepatic Impairment (Child-Pugh B) Patients With Genotype 1b Chronic Hepatitis C Infection: HCVerso3CompletedNCT01830127Phase 2Results posted